Memorial Sloan Kettering Cancer Center; Clinical Trials Office

New York, New York 10021

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Myelogenous Leukemia, Chronic, Neoplasms

Studies at this site

• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• PF-06671008 Dose Escalation Study in Advanced Solid Tumors — Stopped early